NSC 617145
CAS No. 203115-63-3
NSC 617145( NSC617145 )
Catalog No. M13160 CAS No. 203115-63-3
NSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 73 | Get Quote |
|
| 2MG | 42 | Get Quote |
|
| 5MG | 67 | Get Quote |
|
| 10MG | 92 | Get Quote |
|
| 25MG | 167 | Get Quote |
|
| 50MG | 235 | Get Quote |
|
| 100MG | 369 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | 870 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC 617145
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM.
-
DescriptionNSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM; shows no significant inhibition on BLM, FANCJ, ChlR1, RecQ, and UvrD; acts synergistically with very low concentrations of mitomycin C to inhibit proliferation in a WRN-dependent manner and induce DSB and chromosomal abnormalities in FA-D2(-/-) cells.
-
In VitroNSC 617145 (0.75-3 μM; 24-72 hours) shows maximal inhibition of proliferation (98%) at the lowest concentration in a WRN-specific manner in HeLa cells.NSC 617145 (0.75 μM; 6 hours) induces WRN binding to chromatin and proteasomal degradation.In FA-D2-/- cells, NSC 617145 (0.125 μM) acts synergistically with very low concentrations of Mitomycin C to inhibit proliferation in a WRN-dependent manner and induce double-strand breaks (DSB) and chromosomal abnormalities. NSC 617145 exposure results in enhanced accumulation of DNA-PKcs pS2056 foci and Rad51 foci in Mitomycin C-treated FA-deficient cells, suggesting that WRN helicase inhibition prevents processing of Rad51-mediated recombination products and activates NHEJ.NSC 617145, induces cell cycle arrest and apoptosis in human T-cell leukemia virus type 1 (HTLV-1)-transformed adult T-cell leukemia cells. Cell Viability Assay Cell Line:HeLa cells.Concentration:0.75 μM, 1 μM, 1.5 μM, 2 μM, 3 μM Incubation Time:24 hours, 48 hours, 72 hours Result:Inhibited cell proliferation in a WRN-specific manner.Western Blot Analysis Cell Line:HeLa cells Concentration:0.75 μM Incubation Time:6 hours Result:Caused WRN to become degraded by a proteasome-mediated pathway.
-
In Vivo——
-
SynonymsNSC617145
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Repair Protein
-
RecptorDNA Repair Protein
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number203115-63-3
-
Formula Weight400.04
-
Molecular FormulaC13H10Cl4N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (25.00 mM)
-
SMILESCC(C)(CN1C(=O)C(=C(C1=O)Cl)Cl)CN2C(=O)C(=C(C2=O)Cl)Cl
-
Chemical Name1,1'-(2,2-Dimethyl-1,3-propanediyl)bis[3,4-dichloro-1H-pyrrole-2,5-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Aggarwal M, et al. Cancer Res. 2013 Sep 1;73(17):5497-507.
2. Aggarwal M, et al. Cell Cycle. 2013 Oct 15;12(20):3329-35.
3. Moles R, et al. J Hematol Oncol. 2016 Nov 9;9(1):121.
molnova catalog
related products
-
HUHS-015
HUHS-015 (HUHS015)?is a potent, orally active prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitor with IC50 of 0.67 uM.
-
IACS-4619
IACS-4759 potent, selective aminopyrimidine MTH1 (MutT homolog 1) inhibitor with IC50 of 0.2 nM.
-
PFM01
PFM01 (SML1735) is a small molecule that specifically inhibits endonuclease, but not exonuclease activity of MRE11, inhibits dsDNA end resection in A549 cells with IC50 of 50-75 uM, blocks the ssDNA-binding path toward the catalytic metal ions and disrupts endonuclease activity.
Cart
sales@molnova.com